Guoxiang Cai

机构：Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center, Shandong Tumor Hospital, Shandong First Medical University · ORCID：0000-0003-2953-3460

发表论文 94 篇 · 总被引 1931 次 · h-index 27

代表论文

• Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH) (2024 · Journal of Clinical Oncology · 被引 131)
• PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism (2022 · 癌症：英文版 · 被引 112)
• Integrated Multi-Omics Landscape of Liver Metastases (2022 · Gastroenterology · 被引 110)
• Molecular Profiling Provides Clinical Insights Into Targeted and Immunotherapies as Well as Colorectal Cancer Prognosis (2023 · Gastroenterology · 被引 86)
• The ligation between ERMAP, galectin-9 and dectin-2 promotes Kupffer cell phagocytosis and antitumor immunity (2023 · Nature Immunology · 被引 72)
• Microbiome dysbiosis, neutrophil recruitment and mesenchymal transition of mesothelial cells promotes peritoneal metastasis of colorectal cancer (2025 · Nature Cancer · 被引 48)